<scp>SQuID</scp> (subcutaneous insulin in diabetic ketoacidosis): Clinician acceptability

Acceptability was high across clinician types; 65% of ED clinicians preferred SQuID to IV insulin. Clinicians liked SQuID (affective attitude), found it easy to use (burden), were confident in its use (self-efficacy), felt that it improved outcomes (perceived effectiveness), found that it was fair to patients (ethicality), found that it made sense (intervention coherence), and found that it did not interfere with other activities (opportunity cost).

Authors

Institutions

Publication Details

Journal
Academic Emergency Medicine
Published
2024-09-23
DOI
https://doi.org/10.1111/acem.15019
Citations
3
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
1.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SQuID (subcutaneous insulin in diabetic ketoacidosis): Clinician acceptability

Paulina Cruz‐Bravo, Ryan M. Schneider, Richard T. Griffey, Gina LaRossa et al.
3 citations
Academic Emergency Medicine
Diabetes Management and Research
1.07
article

SQuID (subcutaneous insulin in diabetic ketoacidosis): Clinician acceptability

Paulina Cruz‐Bravo, Ryan M. Schneider, Richard T. Griffey, Gina LaRossa, Rachel M. Ancona, Laura Frawley, Julianne Yeary, Margo Girardi, Taylor Kaser, Dan Suarez
article en
3 citations

Abstract

Acceptability was high across clinician types; 65% of ED clinicians preferred SQuID to IV insulin. Clinicians liked SQuID (affective attitude), found it easy to use (burden), were confident in its use (self-efficacy), felt that it improved outcomes (perceived effectiveness), found that it was fair to patients (ethicality), found that it made sense (intervention coherence), and found that it did not interfere with other activities (opportunity cost).

Academic Emergency MedicineVol. 32(1)
Barnes-Jewish Hospital (US), Washington University in St. Louis (US), Saint Louis University Hospital (US), Jewish Hospital (US)
Agency for Healthcare Research and Quality
Openalex Percentile: Top 20%
Diabetes Management and Research
1.07
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<scp>SQuID</scp> (subcutaneous insulin in diabetic ketoacidosis): Clinician acceptability — Paulina Cruz‐Bravo, Ryan M. Schneider, et al. · Academic Emergency Medicine (2024) | TGRS Research Map | TGRS